Anti-Aβ globulomer 5F7 antibodies

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8691224
APP PUB NO 20090191190A1
SERIAL NO

11574876

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Anti-Aβ globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ABBVIE DEUTSCHLAND GMBH & CO. KG;ABBVIE INC.

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Barghorn, Stefan Mannheim, DE 33 596
Ebert, Ulrich Mannheim, DE 33 642
Hillen, Heinz Hassloch, DE 44 705
Keller, Patrick Darmstadt, DE 36 759
Labkovsky, Boris Wales, US 58 4391
Striebinger, Andreas R Speyer, DE 12 383

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 8, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00